TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Patrick W. Serruys
52747

REGISTER for free or LOG IN to view this content

We Recommend